This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $3,695.85, is for the delivery of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products. The contract is a Firm Fixed Price type and does not have a set-aside designation.
Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The current delivery order is one of many the company has received under this larger IDC vehicle.
Generated 3/21/25, 10:03 AM